Develops dietary supplements for heart and skin health.
Jun 2026Revenue $55.0/yrExpenses $115K/yr
No trend
Figures by year
When will Goldenwell Biotech be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $55.0 and expenses $115K.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $55.0 | $113K | −$113K |
| Dec 2024 | $139 | $123K | −$123K |
| Dec 2023 | $1.84K | $118K | −$116K |
| Dec 2022 | $47.8K | $1.03M | −$985K |
| Dec 2021 | $16.0K | $134K | −$118K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.